These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22313164)

  • 41. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
    BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allele.
    Tsui NB; Hyland CA; Gardener GJ; Danon D; Fisk NM; Millard G; Flower RL; Lo YM
    Prenat Diagn; 2013 Dec; 33(12):1214-6. PubMed ID: 23999893
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-D immunization by DEL red blood cells.
    Wagner T; Körmöczi GF; Buchta C; Vadon M; Lanzer G; Mayr WR; Legler TJ
    Transfusion; 2005 Apr; 45(4):520-6. PubMed ID: 15819672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical application of midtrimester non-invasive fetal RHD genotyping and identification of RHD variants in a mixed-ethnic population.
    Grande M; Ordoñez E; Cirigliano V; Cid J; Grau E; Pericot A; Teixido I; Marin JL; Borrell A
    Prenat Diagn; 2013 Feb; 33(2):173-8. PubMed ID: 23280558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation.
    Akolekar R; Finning K; Kuppusamy R; Daniels G; Nicolaides KH
    Fetal Diagn Ther; 2011; 29(4):301-6. PubMed ID: 21212654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noninvasive fetal RhD status determination in early pregnancy.
    Manzanares S; Entrala C; Sánchez-Gila M; Fernández-Rosado F; Cobo D; Martinez E; Molina L; Reche R; Pineda A; Gallo JL
    Fetal Diagn Ther; 2014; 35(1):7-12. PubMed ID: 24335165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
    Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
    Achargui S; Tijane M; Benchemsi N
    Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
    Kent J; Farrell AM; Soothill P
    BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preliminary results of fetal Rhc examination in plasma of pregnant women with anti-c.
    Orzińska A; Guz K; Brojer E; Zupańska B
    Prenat Diagn; 2008 Apr; 28(4):335-7. PubMed ID: 18382999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai.
    Li Q; Hou L; Guo ZH; Ye LY; Yue DQ; Zhu ZY
    Vox Sang; 2009 Aug; 97(2):139-46. PubMed ID: 19490579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.
    Finning K; Martin P; Summers J; Daniels G
    Transfusion; 2007 Nov; 47(11):2126-33. PubMed ID: 17958542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive determination of fetal rh blood group, D antigen status by cell-free DNA analysis in maternal plasma: experience in a Brazilian population.
    Chinen PA; Nardozza LM; Martinhago CD; Camano L; Daher S; Pares DB; Minett T; Araujo Júnior E; Moron AF
    Am J Perinatol; 2010 Nov; 27(10):759-62. PubMed ID: 20408112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.